Rosh Kumar Viasha Sethi, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Head and Neck Neoplasms | 16 | 2022 | 2719 | 1.590 |
Why?
|
| Laryngectomy | 5 | 2020 | 234 | 1.120 |
Why?
|
| Hospital Costs | 4 | 2019 | 976 | 1.120 |
Why?
|
| Neck Injuries | 2 | 2019 | 141 | 1.110 |
Why?
|
| Rhinoplasty | 2 | 2019 | 224 | 1.100 |
Why?
|
| Emergency Service, Hospital | 12 | 2020 | 7499 | 0.980 |
Why?
|
| Otolaryngology | 8 | 2018 | 663 | 0.940 |
Why?
|
| Adenoidectomy | 1 | 2022 | 158 | 0.810 |
Why?
|
| Parotid Gland | 2 | 2018 | 163 | 0.800 |
Why?
|
| Pain, Postoperative | 3 | 2019 | 1629 | 0.760 |
Why?
|
| Analgesics, Opioid | 4 | 2019 | 3409 | 0.730 |
Why?
|
| Natural Orifice Endoscopic Surgery | 1 | 2020 | 127 | 0.700 |
Why?
|
| Drug Prescriptions | 2 | 2018 | 1687 | 0.680 |
Why?
|
| Fractures, Closed | 1 | 2019 | 88 | 0.680 |
Why?
|
| Surgical Flaps | 7 | 2020 | 1634 | 0.670 |
Why?
|
| Fractures, Open | 1 | 2019 | 103 | 0.670 |
Why?
|
| Alphapapillomavirus | 1 | 2021 | 226 | 0.670 |
Why?
|
| Punctures | 2 | 2017 | 366 | 0.610 |
Why?
|
| Epistaxis | 1 | 2017 | 108 | 0.610 |
Why?
|
| Parotid Neoplasms | 1 | 2018 | 162 | 0.600 |
Why?
|
| Hemostatic Techniques | 1 | 2017 | 118 | 0.590 |
Why?
|
| Paranasal Sinuses | 1 | 2018 | 267 | 0.580 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2021 | 457 | 0.570 |
Why?
|
| Health Care Costs | 4 | 2023 | 3164 | 0.570 |
Why?
|
| Reconstructive Surgical Procedures | 6 | 2020 | 2115 | 0.550 |
Why?
|
| Hearing Loss, Sensorineural | 3 | 2018 | 772 | 0.520 |
Why?
|
| Voice | 1 | 2017 | 245 | 0.520 |
Why?
|
| Papillomavirus Infections | 3 | 2022 | 1513 | 0.520 |
Why?
|
| Laryngeal Diseases | 1 | 2017 | 253 | 0.520 |
Why?
|
| Larynx | 1 | 2019 | 468 | 0.510 |
Why?
|
| Economic Competition | 2 | 2014 | 237 | 0.510 |
Why?
|
| Pharyngeal Neoplasms | 1 | 2014 | 121 | 0.500 |
Why?
|
| Larynx, Artificial | 1 | 2014 | 68 | 0.500 |
Why?
|
| Laryngeal Neoplasms | 2 | 2015 | 540 | 0.490 |
Why?
|
| Otorhinolaryngologic Diseases | 1 | 2014 | 93 | 0.490 |
Why?
|
| Carcinoma | 3 | 2014 | 2321 | 0.470 |
Why?
|
| Carcinoma, Squamous Cell | 6 | 2022 | 3994 | 0.470 |
Why?
|
| Rhinitis | 2 | 2018 | 663 | 0.460 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2018 | 1181 | 0.460 |
Why?
|
| Neurites | 1 | 2014 | 390 | 0.450 |
Why?
|
| Hyperpigmentation | 1 | 2012 | 97 | 0.430 |
Why?
|
| Endoscopy | 2 | 2018 | 1756 | 0.430 |
Why?
|
| Minocycline | 1 | 2012 | 162 | 0.430 |
Why?
|
| Retrospective Studies | 38 | 2022 | 72443 | 0.430 |
Why?
|
| Paraganglioma | 1 | 2013 | 147 | 0.420 |
Why?
|
| Esophagus | 1 | 2017 | 1016 | 0.420 |
Why?
|
| Trachea | 1 | 2017 | 1080 | 0.420 |
Why?
|
| Sinusitis | 2 | 2018 | 887 | 0.420 |
Why?
|
| Models, Educational | 1 | 2014 | 395 | 0.410 |
Why?
|
| Hospitals | 4 | 2023 | 3375 | 0.390 |
Why?
|
| SEER Program | 3 | 2020 | 1572 | 0.380 |
Why?
|
| Craniocerebral Trauma | 1 | 2014 | 474 | 0.380 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2013 | 295 | 0.370 |
Why?
|
| Neck Dissection | 3 | 2019 | 216 | 0.360 |
Why?
|
| United States | 29 | 2023 | 67905 | 0.360 |
Why?
|
| Insurance Coverage | 5 | 2020 | 1863 | 0.350 |
Why?
|
| Free Tissue Flaps | 3 | 2022 | 286 | 0.350 |
Why?
|
| Medicare | 3 | 2022 | 5791 | 0.340 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 3 | 2018 | 328 | 0.330 |
Why?
|
| Neural Stem Cells | 1 | 2014 | 894 | 0.310 |
Why?
|
| Postoperative Complications | 6 | 2020 | 15079 | 0.310 |
Why?
|
| Inpatients | 1 | 2018 | 2255 | 0.310 |
Why?
|
| Otitis Media | 2 | 2019 | 281 | 0.300 |
Why?
|
| Hippocampus | 1 | 2019 | 3628 | 0.300 |
Why?
|
| Humans | 80 | 2023 | 715777 | 0.300 |
Why?
|
| Pharyngectomy | 2 | 2017 | 45 | 0.300 |
Why?
|
| Aged | 36 | 2022 | 162448 | 0.290 |
Why?
|
| Head | 2 | 2023 | 850 | 0.290 |
Why?
|
| Middle Aged | 43 | 2022 | 214639 | 0.290 |
Why?
|
| Female | 59 | 2022 | 377204 | 0.290 |
Why?
|
| Patient Protection and Affordable Care Act | 3 | 2020 | 1167 | 0.280 |
Why?
|
| Internship and Residency | 5 | 2018 | 5623 | 0.280 |
Why?
|
| Thyroid Nodule | 1 | 2012 | 738 | 0.270 |
Why?
|
| Male | 56 | 2022 | 350324 | 0.270 |
Why?
|
| Glioma | 1 | 2019 | 3302 | 0.270 |
Why?
|
| Sentinel Lymph Node Biopsy | 2 | 2019 | 671 | 0.250 |
Why?
|
| Mouth Neoplasms | 2 | 2020 | 617 | 0.250 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2013 | 1154 | 0.240 |
Why?
|
| Hospitalization | 4 | 2020 | 9745 | 0.240 |
Why?
|
| Emergency Medical Services | 1 | 2014 | 1794 | 0.230 |
Why?
|
| Skin Neoplasms | 2 | 2019 | 5318 | 0.230 |
Why?
|
| Osteoradionecrosis | 1 | 2022 | 55 | 0.230 |
Why?
|
| Adult | 33 | 2022 | 212266 | 0.230 |
Why?
|
| Healthcare Disparities | 1 | 2017 | 3035 | 0.220 |
Why?
|
| Middle Ear Ventilation | 1 | 2022 | 100 | 0.210 |
Why?
|
| Adolescent | 19 | 2022 | 85155 | 0.210 |
Why?
|
| Nasolacrimal Duct | 1 | 2022 | 72 | 0.210 |
Why?
|
| Child | 16 | 2022 | 74468 | 0.210 |
Why?
|
| Neoplasms, Unknown Primary | 1 | 2022 | 105 | 0.210 |
Why?
|
| Medicare Part B | 1 | 2022 | 111 | 0.200 |
Why?
|
| Surgical Stomas | 1 | 2020 | 45 | 0.200 |
Why?
|
| Young Adult | 16 | 2020 | 56226 | 0.200 |
Why?
|
| Child, Preschool | 13 | 2020 | 41198 | 0.190 |
Why?
|
| Melanoma | 1 | 2018 | 5250 | 0.190 |
Why?
|
| Papillomaviridae | 3 | 2022 | 1139 | 0.190 |
Why?
|
| Endovascular Procedures | 1 | 2013 | 1925 | 0.190 |
Why?
|
| Massachusetts | 4 | 2019 | 8743 | 0.190 |
Why?
|
| Thyroid Neoplasms | 1 | 2012 | 2225 | 0.180 |
Why?
|
| Hyperacusis | 1 | 2019 | 28 | 0.180 |
Why?
|
| Labyrinthitis | 1 | 2018 | 30 | 0.170 |
Why?
|
| Job Application | 1 | 2018 | 40 | 0.170 |
Why?
|
| Mastoiditis | 1 | 2018 | 34 | 0.170 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2018 | 20356 | 0.170 |
Why?
|
| Preoperative Care | 2 | 2018 | 2344 | 0.170 |
Why?
|
| Logistic Models | 7 | 2020 | 13618 | 0.170 |
Why?
|
| Salvage Therapy | 3 | 2021 | 1304 | 0.160 |
Why?
|
| Brain Abscess | 1 | 2018 | 117 | 0.160 |
Why?
|
| Treatment Outcome | 17 | 2021 | 62004 | 0.160 |
Why?
|
| Aged, 80 and over | 10 | 2021 | 58323 | 0.160 |
Why?
|
| Ranula | 1 | 2017 | 11 | 0.160 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2019 | 228 | 0.160 |
Why?
|
| Tinnitus | 1 | 2019 | 166 | 0.160 |
Why?
|
| Cross-Sectional Studies | 6 | 2023 | 23438 | 0.160 |
Why?
|
| Audiometry | 1 | 2018 | 254 | 0.160 |
Why?
|
| Jugular Veins | 1 | 2018 | 213 | 0.150 |
Why?
|
| Cell Differentiation | 1 | 2014 | 11655 | 0.150 |
Why?
|
| Meningitis | 1 | 2018 | 226 | 0.150 |
Why?
|
| Neuroma, Acoustic | 1 | 2020 | 439 | 0.150 |
Why?
|
| Combined Modality Therapy | 4 | 2017 | 8890 | 0.150 |
Why?
|
| After-Hours Care | 1 | 2017 | 105 | 0.150 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 2019 | 262 | 0.150 |
Why?
|
| Personnel Selection | 1 | 2018 | 198 | 0.150 |
Why?
|
| Tracheostomy | 1 | 2020 | 400 | 0.150 |
Why?
|
| Cochlear Implantation | 1 | 2020 | 279 | 0.140 |
Why?
|
| Clavicle | 2 | 2015 | 185 | 0.140 |
Why?
|
| Neck | 1 | 2020 | 708 | 0.140 |
Why?
|
| Glossectomy | 1 | 2015 | 53 | 0.140 |
Why?
|
| Cochlear Implants | 1 | 2020 | 301 | 0.140 |
Why?
|
| Cohort Studies | 8 | 2020 | 40029 | 0.140 |
Why?
|
| Diagnostic Techniques, Otological | 1 | 2015 | 12 | 0.140 |
Why?
|
| Supratentorial Neoplasms | 2 | 2013 | 160 | 0.140 |
Why?
|
| Education, Medical, Graduate | 3 | 2017 | 2207 | 0.140 |
Why?
|
| Auditory Brain Stem Implants | 1 | 2014 | 33 | 0.130 |
Why?
|
| Multivariate Analysis | 5 | 2018 | 12480 | 0.130 |
Why?
|
| Device Approval | 1 | 2017 | 197 | 0.130 |
Why?
|
| Acetaminophen | 1 | 2019 | 551 | 0.130 |
Why?
|
| Facial Paralysis | 1 | 2018 | 326 | 0.130 |
Why?
|
| Speech Disorders | 1 | 2015 | 179 | 0.130 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2022 | 1016 | 0.130 |
Why?
|
| Outpatients | 1 | 2021 | 1371 | 0.130 |
Why?
|
| Tongue Neoplasms | 1 | 2015 | 175 | 0.130 |
Why?
|
| Maxillary Sinus Neoplasms | 1 | 2014 | 42 | 0.130 |
Why?
|
| Area Under Curve | 1 | 2018 | 1687 | 0.120 |
Why?
|
| Telephone | 1 | 2017 | 631 | 0.120 |
Why?
|
| Medically Uninsured | 1 | 2019 | 866 | 0.120 |
Why?
|
| Lymphatic Metastasis | 2 | 2019 | 2968 | 0.120 |
Why?
|
| Insurance, Health | 3 | 2022 | 2497 | 0.120 |
Why?
|
| Hospitals, Teaching | 1 | 2018 | 1153 | 0.120 |
Why?
|
| Ear Diseases | 1 | 2015 | 178 | 0.120 |
Why?
|
| Infant | 10 | 2020 | 34569 | 0.110 |
Why?
|
| Neuroectodermal Tumors, Primitive | 1 | 2013 | 140 | 0.110 |
Why?
|
| Blood Transfusion | 1 | 2018 | 1257 | 0.110 |
Why?
|
| Forecasting | 2 | 2020 | 2956 | 0.110 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2017 | 498 | 0.110 |
Why?
|
| Stethoscopes | 1 | 2012 | 27 | 0.110 |
Why?
|
| Hearing Loss | 1 | 2019 | 722 | 0.110 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2014 | 240 | 0.110 |
Why?
|
| Acute Disease | 3 | 2018 | 7140 | 0.110 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2021 | 8896 | 0.110 |
Why?
|
| Disability Evaluation | 1 | 2019 | 1821 | 0.100 |
Why?
|
| Bibliometrics | 1 | 2015 | 338 | 0.100 |
Why?
|
| Neoplasm Staging | 5 | 2020 | 11145 | 0.100 |
Why?
|
| Rhabdoid Tumor | 1 | 2013 | 207 | 0.100 |
Why?
|
| Accreditation | 1 | 2014 | 446 | 0.100 |
Why?
|
| Ophthalmology | 1 | 2017 | 489 | 0.100 |
Why?
|
| Neoadjuvant Therapy | 1 | 2021 | 2556 | 0.100 |
Why?
|
| Coculture Techniques | 1 | 2014 | 1353 | 0.100 |
Why?
|
| Arteries | 1 | 2015 | 1084 | 0.100 |
Why?
|
| Models, Organizational | 1 | 2014 | 583 | 0.100 |
Why?
|
| Ependymoma | 1 | 2013 | 326 | 0.100 |
Why?
|
| ROC Curve | 1 | 2018 | 3524 | 0.100 |
Why?
|
| Lower Extremity | 1 | 2018 | 1043 | 0.100 |
Why?
|
| Teratoma | 1 | 2013 | 390 | 0.100 |
Why?
|
| Risk Assessment | 6 | 2019 | 23464 | 0.100 |
Why?
|
| Multiple Organ Failure | 1 | 2012 | 377 | 0.100 |
Why?
|
| Cost-Benefit Analysis | 3 | 2020 | 5265 | 0.100 |
Why?
|
| Disinfection | 1 | 2012 | 201 | 0.090 |
Why?
|
| Deglutition Disorders | 1 | 2015 | 574 | 0.090 |
Why?
|
| Needs Assessment | 1 | 2016 | 1147 | 0.090 |
Why?
|
| Prognosis | 4 | 2021 | 29005 | 0.090 |
Why?
|
| Patient Preference | 1 | 2017 | 867 | 0.090 |
Why?
|
| Memory | 1 | 2019 | 2143 | 0.090 |
Why?
|
| Radiotherapy, Conformal | 1 | 2013 | 564 | 0.090 |
Why?
|
| Ischemia | 1 | 2018 | 1906 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 2 | 2014 | 3681 | 0.090 |
Why?
|
| Survivors | 1 | 2019 | 2171 | 0.090 |
Why?
|
| Registries | 3 | 2020 | 8045 | 0.090 |
Why?
|
| Ulnar Nerve | 1 | 1989 | 110 | 0.090 |
Why?
|
| Health Services Needs and Demand | 1 | 2017 | 1437 | 0.090 |
Why?
|
| Urination Disorders | 1 | 1989 | 246 | 0.080 |
Why?
|
| Surgical Wound Infection | 1 | 2018 | 1498 | 0.080 |
Why?
|
| Cerebellar Neoplasms | 1 | 2013 | 603 | 0.080 |
Why?
|
| Reflex | 1 | 1989 | 353 | 0.080 |
Why?
|
| United States Food and Drug Administration | 1 | 2017 | 1778 | 0.080 |
Why?
|
| Socioeconomic Factors | 2 | 2019 | 7757 | 0.080 |
Why?
|
| Diffusion of Innovation | 1 | 2013 | 715 | 0.080 |
Why?
|
| Brain Concussion | 1 | 2019 | 1284 | 0.080 |
Why?
|
| Publishing | 1 | 2015 | 805 | 0.080 |
Why?
|
| Motor Neurons | 2 | 1989 | 799 | 0.080 |
Why?
|
| Peripheral Arterial Disease | 1 | 2018 | 1113 | 0.080 |
Why?
|
| Self Report | 1 | 2018 | 3416 | 0.080 |
Why?
|
| Medulloblastoma | 1 | 2013 | 721 | 0.080 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2012 | 1059 | 0.080 |
Why?
|
| Disease-Free Survival | 4 | 2021 | 7015 | 0.080 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2013 | 1834 | 0.080 |
Why?
|
| Linear Models | 2 | 2019 | 5983 | 0.080 |
Why?
|
| Brachial Plexus | 1 | 1989 | 169 | 0.080 |
Why?
|
| Venous Thrombosis | 1 | 2016 | 1216 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2016 | 6501 | 0.080 |
Why?
|
| Carcinoma, Papillary | 1 | 2012 | 793 | 0.080 |
Why?
|
| Medicaid | 1 | 2020 | 2649 | 0.080 |
Why?
|
| Patient Admission | 1 | 2015 | 1396 | 0.080 |
Why?
|
| Thyroidectomy | 1 | 2012 | 887 | 0.080 |
Why?
|
| Graft Survival | 2 | 2014 | 3750 | 0.080 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2021 | 11236 | 0.080 |
Why?
|
| Tissue and Organ Procurement | 1 | 2014 | 856 | 0.070 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2018 | 2937 | 0.070 |
Why?
|
| Survival Rate | 3 | 2019 | 13206 | 0.070 |
Why?
|
| Propensity Score | 1 | 2013 | 1759 | 0.070 |
Why?
|
| Thyroid Gland | 1 | 2012 | 1158 | 0.070 |
Why?
|
| Patient Selection | 2 | 2014 | 4293 | 0.070 |
Why?
|
| Telemedicine | 1 | 2022 | 2608 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2018 | 9030 | 0.070 |
Why?
|
| Hospital Mortality | 1 | 2019 | 5132 | 0.070 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2013 | 868 | 0.070 |
Why?
|
| Age Factors | 2 | 2018 | 18784 | 0.060 |
Why?
|
| Health Surveys | 1 | 2014 | 4036 | 0.060 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 13643 | 0.060 |
Why?
|
| Databases, Factual | 4 | 2019 | 7895 | 0.060 |
Why?
|
| Cross Infection | 1 | 2012 | 1409 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 14902 | 0.060 |
Why?
|
| Quality Indicators, Health Care | 1 | 2013 | 1825 | 0.060 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 5038 | 0.060 |
Why?
|
| Students, Medical | 1 | 2014 | 1769 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2014 | 39300 | 0.050 |
Why?
|
| Morbidity | 2 | 2019 | 1715 | 0.050 |
Why?
|
| Length of Stay | 3 | 2020 | 6267 | 0.050 |
Why?
|
| Curriculum | 1 | 2014 | 3402 | 0.050 |
Why?
|
| Negotiating | 1 | 2022 | 129 | 0.050 |
Why?
|
| Graft Rejection | 1 | 2014 | 4396 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 15909 | 0.050 |
Why?
|
| Leuprolide | 1 | 2022 | 308 | 0.050 |
Why?
|
| Myoglobinuria | 1 | 1999 | 23 | 0.050 |
Why?
|
| Odds Ratio | 1 | 2013 | 9984 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 19537 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2018 | 21797 | 0.050 |
Why?
|
| Electric Injuries | 1 | 1999 | 27 | 0.050 |
Why?
|
| Frozen Sections | 1 | 2020 | 164 | 0.050 |
Why?
|
| Humidity | 1 | 2020 | 192 | 0.050 |
Why?
|
| Infant, Newborn | 5 | 2020 | 24798 | 0.050 |
Why?
|
| Kidney Transplantation | 1 | 2014 | 4140 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2012 | 11689 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2015 | 3268 | 0.050 |
Why?
|
| Clinical Competence | 1 | 2014 | 4630 | 0.040 |
Why?
|
| Hospital Charges | 1 | 2020 | 362 | 0.040 |
Why?
|
| Forearm | 1 | 2020 | 406 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2012 | 3902 | 0.040 |
Why?
|
| Prevalence | 1 | 2014 | 14911 | 0.040 |
Why?
|
| Protons | 1 | 2022 | 1065 | 0.040 |
Why?
|
| Growth Disorders | 1 | 2022 | 656 | 0.040 |
Why?
|
| Parotid Diseases | 1 | 2017 | 45 | 0.040 |
Why?
|
| Hematocrit | 1 | 2018 | 637 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 13217 | 0.040 |
Why?
|
| Incidence | 3 | 2020 | 20731 | 0.040 |
Why?
|
| Reoperation | 2 | 2018 | 4169 | 0.040 |
Why?
|
| Liver Function Tests | 1 | 2018 | 534 | 0.040 |
Why?
|
| Risk Factors | 4 | 2017 | 70866 | 0.040 |
Why?
|
| Equipment Safety | 1 | 2017 | 274 | 0.040 |
Why?
|
| Cost Savings | 1 | 2021 | 916 | 0.040 |
Why?
|
| Blood Chemical Analysis | 1 | 2018 | 461 | 0.040 |
Why?
|
| Limb Salvage | 1 | 2018 | 423 | 0.040 |
Why?
|
| Hospitals, Pediatric | 2 | 2017 | 1776 | 0.040 |
Why?
|
| Kidney Function Tests | 1 | 2018 | 697 | 0.030 |
Why?
|
| Cause of Death | 2 | 2019 | 3612 | 0.030 |
Why?
|
| Speech Intelligibility | 1 | 2015 | 68 | 0.030 |
Why?
|
| Neurons | 1 | 2014 | 9375 | 0.030 |
Why?
|
| Hot Temperature | 1 | 2020 | 1322 | 0.030 |
Why?
|
| Laminin | 1 | 1996 | 418 | 0.030 |
Why?
|
| Pharynx | 1 | 2017 | 417 | 0.030 |
Why?
|
| Electromyography | 2 | 1989 | 1372 | 0.030 |
Why?
|
| Muscular Dystrophies | 1 | 1996 | 395 | 0.030 |
Why?
|
| Neoplasms | 1 | 2022 | 20528 | 0.030 |
Why?
|
| Sex Factors | 2 | 2018 | 10666 | 0.030 |
Why?
|
| Quality of Life | 1 | 2014 | 11721 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2018 | 1843 | 0.030 |
Why?
|
| Amputation | 1 | 2018 | 763 | 0.030 |
Why?
|
| Gastrostomy | 1 | 2015 | 301 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2018 | 10499 | 0.030 |
Why?
|
| Duodenal Neoplasms | 1 | 2012 | 108 | 0.030 |
Why?
|
| Infratentorial Neoplasms | 1 | 2013 | 100 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2013 | 8805 | 0.030 |
Why?
|
| Drug Costs | 1 | 2020 | 1170 | 0.030 |
Why?
|
| Muscles | 1 | 1996 | 1556 | 0.030 |
Why?
|
| Income | 1 | 2020 | 1822 | 0.030 |
Why?
|
| Endocrine System Diseases | 1 | 2013 | 252 | 0.030 |
Why?
|
| Leucovorin | 1 | 2012 | 596 | 0.030 |
Why?
|
| Organoplatinum Compounds | 1 | 2012 | 429 | 0.030 |
Why?
|
| Triage | 1 | 2017 | 933 | 0.020 |
Why?
|
| Cranial Irradiation | 1 | 2013 | 441 | 0.020 |
Why?
|
| Nausea | 1 | 2012 | 655 | 0.020 |
Why?
|
| Camptothecin | 1 | 2012 | 551 | 0.020 |
Why?
|
| Vomiting | 1 | 2012 | 625 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2015 | 1669 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2015 | 2371 | 0.020 |
Why?
|
| Patients | 1 | 2015 | 773 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2017 | 2512 | 0.020 |
Why?
|
| Workload | 1 | 2015 | 858 | 0.020 |
Why?
|
| Age Distribution | 1 | 2015 | 2942 | 0.020 |
Why?
|
| Career Choice | 1 | 2014 | 743 | 0.020 |
Why?
|
| Medication Adherence | 1 | 2020 | 2046 | 0.020 |
Why?
|
| Poverty | 1 | 2020 | 2620 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2020 | 3030 | 0.020 |
Why?
|
| Fluorouracil | 1 | 2012 | 1610 | 0.020 |
Why?
|
| Educational Status | 1 | 2015 | 2353 | 0.020 |
Why?
|
| Neural Conduction | 1 | 1989 | 478 | 0.020 |
Why?
|
| Acute Kidney Injury | 1 | 1999 | 1886 | 0.020 |
Why?
|
| Radiotherapy Dosage | 1 | 2013 | 2947 | 0.020 |
Why?
|
| Demyelinating Diseases | 1 | 1989 | 367 | 0.020 |
Why?
|
| Body Height | 1 | 2013 | 1609 | 0.020 |
Why?
|
| Central Nervous System | 1 | 2013 | 1291 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 20062 | 0.020 |
Why?
|
| Neural Inhibition | 1 | 1989 | 590 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2014 | 2151 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2013 | 3551 | 0.020 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1989 | 703 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6722 | 0.010 |
Why?
|
| Animals | 1 | 2014 | 169420 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 15199 | 0.010 |
Why?
|
| Action Potentials | 1 | 1989 | 1780 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2013 | 6873 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 12456 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2015 | 4279 | 0.010 |
Why?
|
| Health Personnel | 1 | 2012 | 3045 | 0.010 |
Why?
|
| Compartment Syndromes | 1 | 1999 | 146 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2012 | 6324 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 1996 | 707 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2018 | 51315 | 0.010 |
Why?
|
| Time Factors | 1 | 2014 | 40875 | 0.010 |
Why?
|
| Heart Arrest | 1 | 1999 | 1374 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 13626 | 0.010 |
Why?
|
| Burns | 1 | 1999 | 1790 | 0.010 |
Why?
|